A six-month, prospective, multicenter, open label, parallel, randomized study of the safety, tolerability and efficacy of EC-MPS with basiliximab corticosteroids and two different levels of tacrolimus in de novo renal transplant recipients.
Phase of Trial: Phase IV
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Novartis
- 28 Jan 2011 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 23 Nov 2005 New trial record.